Loading, please wait...
Date: Apr 14, 2024 02:00 PM - Apr 20, 2024 04:00 PM
CE Hours
2.00
CE Units
0.200
Registration closes on Jun 03, 2024 11:55 PM
Activity Type
- Knowledge
Target Audience(s)
- PHARMACY TECHNICIANS
- Pharmacists
Objectives
- Explain the physiological function of glucagon-like peptide (GLP1) and gastric inhibitory peptide (GIP)
- Examine scientific evidence supporting the application of incretin mimetics in specific diseases (P).
- List potential side effects or adverse reactions associated with GLP1 and GIP Inhibitors and outline management strategies
- Differentiate between various dosage forms of GLP1 and GIP Inhibitors
- Provide key counseling points for each
Activity Number
0151-0000-24-009-L01-P
Date:
04/14/24 08:00 AM - 04/20/24 11:55 PM
CE Hours
2.00